LOGO
LOGO

FDA Calendar - Lantheus Holdings Inc.

Company Name Lantheus Holdings Inc.
LNTH
Drug Name MK-6240, a PET Imaging Agent (NDA)
Event Name FDA decision on MK-6240, a PET Imaging Agent, for the detection of tau neurofibrillary tangle (NFT) pathology in patients with cognitive impairment being evaluated for Alzheimer’s disease
Event Date 08/13/2026
Outcome Date
Outcome Pending
Drug Status
Rival Drugs Tauvid, developed by Eli Lilly's subsidiary Avid Radiopharmaceuticals
Market Potential
Other Approvals
News
RELATED NEWS (Lantheus Holdings Inc.)